5VM
PEAR

5AM Venture Management’s Pear Therapeutics, Inc. Class A Common Stock PEAR Stock Holding History

5AM Venture Management’s Portfolio PEAR Stock Details PEAR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-16,744,113
Closed -$4.27M – 28
2023
Q1 		$4.27M Hold
16,744,113
– – 1.09% 21
2022
Q4 		$19.8M Sell
16,744,113
-159,490
-0.9% -$335K 5.31% 6
2022
Q3 		$34.5M Sell
16,903,603
-1,728,168
-9% -$2.93M 6.61% 4
2022
Q2 		$28.7M Hold
18,631,771
– – 7.1% 4
2022
Q1 		$94.1M Hold
18,631,771
– – 20.55% 1
2021
Q4 		$116M Buy
+18,631,771
New +$166M 21.68% 1

5AM Venture Management's PEAR Position: Q2 2023 in Review

5AM Venture Management sold out of Pear Therapeutics, Inc. Class A Common Stock (PEAR) in Q2 2023, closing a stake of 16,744,113 shares — an estimated $4.27M sold.

5AM Venture Management first reported a position in PEAR in Q4 2021 and held it in 6 quarters. The position peaked at $116M in Q4 2021. 1 fund tracked by Wall St. Rank holds PEAR as of Q2 2023.

  • 5AM Venture Management reported no remaining Pear Therapeutics, Inc. Class A Common Stock position as of Q2 2023 after selling out during the quarter.
  • 5AM Venture Management sold 16,744,113 Pear Therapeutics, Inc. Class A Common Stock shares in Q2 2023, an estimated $4.27M.
  • 5AM Venture Management first reported a position in Pear Therapeutics, Inc. Class A Common Stock in Q4 2021 and held it in 6 quarters.
  • 5AM Venture Management's Pear Therapeutics, Inc. Class A Common Stock position peaked at $116M in Q4 2021.
  • 1 fund tracked by Wall St. Rank held Pear Therapeutics, Inc. Class A Common Stock as of Q2 2023.

Based on 5AM Venture Management's 13F filing for Q2 2023, filed 14 Aug 2023.